Patrick Hughes


How ICH E6 (R2) Provides a Win/Win/Win through Risk-Based Study Execution

September 18, 2019

The industry-wide shift towards RBx is not only reducing risk, but improving oversight and boosting proactive, predictive decision making, writes Cluepoints' CCO, Patrick Hughes.

How Small and Medium-Sized Businesses Can Capitalize on New ICH E6 Regulations

August 08, 2018

Small and medium-sized businesses are seeking clarification on how the new ICH E6 guidelines will impact their business.

ICH E6 R2 Roundtable Review

August 07, 2017

The release of the ICH E6 R2 guidance, which outlines a new approach to clinical trials operations, will have a major impact on the industry, writes Patrick Hughes.